Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|April 13, 2016
A targeted controlled force injection of genetic material in vivoGustaf Ahlén, Lars Frelin, Fredrik Holmström, et al.Scientific Reports|May 5, 2016
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsesFredrik Holmström, Margaret Chen, Anangi Balasiddaiah, et al.Gut|June 25, 2017
Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse modelSepideh Levander, Fredrik Holmström, Lars Frelin, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 4, 2013
A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic miceFredrik Holmström, Anna Pasetto, Veronica Nähr, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 25, 2011
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccinationAntony Chen, Gustaf Ahlén, Erwin D Brenndörfer, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidityAnna Pasetto, Lars Frelin, Soo Aleman, et al.The Journal of Infectious Diseases|June 19, 2013
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virusAnne Fournillier, Lars Frelin, Emilie Jacquier, et al.Nature Communications|February 6, 2019
Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain developmentKatarína Tiklová, Åsa K Björklund, Laura Lahti, et al.Pageof 1